Abstract: Recent research indicates that the origin of obesity and related metabolic disorders is not only caused by genetic and risk factors in adult life (unbalanced diet, insufficient physical activity) but also may be influenced by the perinatal environment. In addition, studies in animal models suggest that the mesenchymal stem cell commitment into pre-adipocytes can already occur during fetal development and perinatal life. Since the number of pre-adipocytes and mature adipocytes is lower in normal subjects than in obese subjects, changes in the prenatal maturational process may play a role in the pathogenesis of obesity and metabolic-associated diseases. Hyperglycemia during pregnancy is related to an increased risk of obesity, early onset of metabolic syndrome and type 2 diabetes in the offspring. For this reason it would be useful to investigate how the perinatal environment may affect fetal mesenchymal stem cells, especially in deregulated gestational diabetes, where the fetal environment is modified in terms of hormone levels and nutrition. Therefore, we have compared Wharton's jelly mesenchymal stem cells (WJ-MSC) obtained from umbilical cord of both healthy and diabetic mothers, in order to better understand the mechanisms involved in metabolic diseases in offspring of diabetic mothers. Results indicate that WJ-MSC from diabetic mothers display, in contrast to cells from healthy mothers, a higher ability to differentiate towards the adipogenic lineage. This suggests that the diabetic uterine environment may be responsible for a "pre-commitment" that could give rise in the post natal life to an alteration of adipocyte production upon an incorrect diet style, which in turn would produce obesity.
INTRODUCTION
The strict glycemic control is a fundamental factor for reducing maternal and fetal morbidity and complications related to diabetic pregnancies, in cases of pregestational diabetes and in cases of first recognition and diagnosis during pregnancy (Gestational Diabetes Mellitus, GDM). Pregestational diabetes is a known risk factor for defects of the cardiovascular, central nervous, and musculoskeletal systems, even though very important studies indicate that the risk of malformations increases continuously with increasing maternal glycemia during the first 6-8 weeks of gestation. Among diabetic women with good glycemic control, the prevalence of complications and malformations is similar to that in the general population. Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy [1] . This condition occurs in 1 to 14 % of all pregnancies depending on population characteristics. Recent evidence indicates a worrisome and significant increase in the prevalence of gestational diabetes related to the increase of maternal obesity [2] [3] [4] [5] . In ! *Address correspondence to this author at the Department of Medicine and Aging Science, Università "G.d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66013 Chieti, Italy; Tel: ++39 08713554571; Fax: ++39 08713554568; E-mail: s.miscia@unich.it healthy pregnant women characteristic changes in maternal metabolism provide nutrients for fetal growth while preserving maternal health [6] , when pregnancy is complicated by diabetes, a series of maternal-fetal complications can occur [7, 8] : development in a diabetic intrauterine environment results in excess fetal growth [4] . The Pedersen hypothesis suggests that maternal hyperglycemia, which is characteristic in diabetes, stimulates fetal pancreas to produce insulin which causes excessive growth or macrosomia [9] . In any case the direct effect of abnormal maternal carbohydrate metabolism is very difficult to be assessed: GDM reflects a metabolically altered fetal environment associated with perinatal morbidity, high birth weight which is also related to later obesity [10] [11] [12] . When hyperglycemia occurs during pregnancy (pre gestational diabetes or GDM), there could be malformations, increased fetal growth, maternal and fetal morbidity and increased risk of developing obesity and type 2 diabetes in life [5] . High maternal glucose concentrations are thought to increase maternal weight gain, resulting in feto-placental overgrowth as well as a higher risk of fetal macrosomia, while low maternal glycaemic diets result in normal maternal weight gain and produces infants with birth weights between the 25th and 50th percentile [13] . Recent studies have shown a relationship between elevated maternal glucose concentrations during gestation and increased birth weight and fetal adiposity [14, 15] . The above evidences call to mind the need of a control of the glucose levels before and during pregnancy in order to prevent maternal and fetal complications and to help reducing maternal and fetal trauma at parturition, as well as the risk of obesity-related adult diseases later in the life. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs), obtained from full term fetal membranes immediately after delivery, possess pluripotent characteristics for high "ex-vivo" expansion potential and ability to differentiate into multiple lineages such as bone, cartilage, fat, muscle, liver, heart and brain cells [16] [17] [18] [19] [20] . Unlike the isolation of stem cells from other sources, such as embryos and bone marrow, the isolation of WJ-MSCs is a "non invasive" proceedings and does not have surrounding moral or ethical issues [21, 22] . Furthermore, WJ-MSCs have a higher proliferation rate and self-renewal capacity compared to other adult stem cells [23, 24] . In human studies it has been shown that both, the size increase of existing adipocytes and the differentiation of new mature fat cells from mesenchymal precursor cells are mechanisms in developing obesity [25] . This process, called adipogenesis, consists of two related steps: the determination of human mesenchymal stem cells into preadipocytes and the differentiation of preadipocytes into mature fat cells [26] . A recent study in rodents suggests that the determination of mesenchymal stem cells into preadipocytes might occur in very early stages of development, e.g. perinatal life [27] . Since the number of preadipocytes and mature fat cells has been shown to be different between lean and obese human adult subjects [28] , variations in the determination process in early stages of adipose tissue development might be important in the pathogenesis of obesity and type 2 diabetes. For this reason it would be useful to investigate how the perinatal environment may affect fetal mesenchymal stem cells, especially in deregulated gestational diabetes, where the fetal environment is modified in terms of hormone levels and nutrition. Therefore, we have compared Wharton's jelly mesenchymal stem cells (WJ-MSC) obtained from umbilical cord in healthy and diabetic women, in order to better understand the mechanisms involved in metabolic diseases in offspring of diabetic mothers.
MATERIAL AND METHODS

Subjects
Five healthy and five diabetic pregnant donors were recruited for this study. The study was performed according to the declaration of Helsinki and subsequent revisions [29] . All participants gave informed consent.
Cell Isolation and Cell Culture
Cell culture institutional review board approval was obtained for all procedures. With the consent of the parents, fresh human umbilical cords were obtained from full-term births; they were aseptically stored in sterile saline solution and processed within 6 hours from partum to obtain umbilical cord mesenchymal stem cells. After the removal of blood vessels, the abundant extracellular matrix of Wharton's jelly was scraped off by a scalpel, finally cutted and centrifuged at 250 X g for 5 minutes at RT; pellets were washed with serum-free Dulbecco's modified Eagle's medium (D-MEM) (Lonza). Next, cells were treated with collagenase type IV (2 mg/ml) (Sigma) for 16 hours at 37ºC, washed in PBS, and treated with 2.5 % trypsin-EDTA (GIBCO) for 30 minutes at 37 ºC under agitation. Finally, cells were washed in PBS and seeded in complete growth medium (HMSCGM) with growth supplements (all from Lonza), in 5 % CO 2 in a 37 ºC incubator. Cells were cultured exchanging the medium every 3-4 days until reaching confluence. Adherent cells were detached with 0.05 % trypsin-EDTA, counted by Trypan Blue exclusion test, and re-seeded at 3000 cells/cm 2 to reach the 90 % of confluence after 3-4 population doublings [30] .
Osteogenic Differentiation
Cells were plated at a density of 3 x 10 3 cells/cm 2 and induced to osteogenic differentiation using αMEM (Sigma) 10% FBS supplemented with 10 mM beta-glycerophosphate (Sigma), 0.2 mM ascorbic acid (Sigma) and 10 -8 M dexamethasone (Sigma). The medium was changed every 3-4 days for the whole process of differentiation (3 weeks). Osteogenic differentiation was assessed by detection of alkaline phosphatase reactivity [31] and by Alizarin Red S staining [32] .
Adipogenic Differentiation
Cells were plated at a density of 2 x 10 4 cells/cm 2 and cultured in DMEM high glucose (HG) (Sigma) 10 % FBS, supplemented with 0.5 mM isobutyl methylxanthine (Sigma), 200 µM indomethacin (Sigma), 10 -6 M dexamethasone (Sigma) and 10µg/ml insulin (Sigma) (induction medium). The differentiation was achieved by alternating cycles every 2-3 days of induction and maintenance (supplemented with only insulin) medium until the end of the process (3 weeks). Cells were finally fixed with a solution containing 10 % formalin and stained with fresh oil red O (Sigma) [31] . Real-Time RT-PCR differentiation assessment was performed at term of two weeks of adipogenic induction.
Morphological Images and Elaboration
Slides were observed with a microscope i50 (Nikon) and images were acquired with a Cool-SNAPcf digital CCD camera (PhotoMetrics, Huntington Beach, CA). Digital processing and elaboration were performed by MetaMorph software (Molecular Devices).
Real-Time RT-PCR
Total RNA was extracted using the RNeasy Plus Minikit (QIAGEN Inc., Valencia, CA) following the manufacturer's instructions. Reverse transcription was performed with the M-MLV Reverse Transcriptase (Sigma). Real-Time RT-PCR for peroxisome proliferator activated receptor gamma (PPARγ) and fatty acid binding protein 4 (FABP4) was carried out with the ABI Prism 7900 Sequence Detection System, using commercially available TaqMan Gene Expression Assays (FABP4, Hs01086177_m1, PPARγ, Hs01115513_m1) and the TaqMan universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA) according to standard protocols. Beta-2 microglobulin (B2M, Hs99999907_m1) (Applied Biosystems, Foster City, CA, USA) was used for template normalization and experimental control as calibrator. Results were analyzed using the 2 -∆∆Ct relative quantification method [33] .
Antibodies
Fluorescein isothiocyanate-conjugated anti-CD13 (CD13-FITC), FITC-conjugated anti-CD44 (CD44-FITC), FITC-conjugated anti-CD45 (CD45-FITC), phycoerythrinconjugated anti-CD29 (CD29-PE), FITC-conjugated anti-CD105 (CD105-FITC) and FITC-conjugated anti-CD166 (CD166-FITC) were obtained from Ancell (MN, USA); FITC-conjugated anti-CD14 (CD14-FITC) and PE-conjugated anti-CD133 (CD133-PE) were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany); FITCconjugated anti-CD90 (CD90-FITC), PE-conjugated anti-CD73 (CD73-PE), PE-Cy5,5-conjugated anti-ESA (ESA-PE-Cy5,5), Alexa488-conjugated Sox2 (Sox2-Alexa488), FITC-conjugated anti-SSEA4 (SSEA4-FITC), PE-conjugated anti-CD146 (CD146-PE), PE-conjugated anti-OCT3/4 (OCT3/4-PE), allophycocyanin-conjugated anti-CD117 (CD117-APC), PE-conjugated anti-CD271 (CD271-PE) and PE-conjugated anti-KDR (KDR-PE) were obtained from Becton Dickinson (BD, San Jose, CA); FITC-conjugated anti-CD144 (CD144-FITC) was obtained from Acris Antibodies (Herford, Germany); PE-conjugated anti-CD34 (CD34-PE) was purchased from Beckman Coulter (Fullerton, CA, USA); TERT primary antibody was obtained from Calbiochem (Dermastadt, Germany) and appropriate secondary FITC-conjugated antibody was obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA).
Flow Cytometry Staining
Washing buffer (PBS 0.1 % sodium azide and 0.5 % bovine serum albumine), was used for all washing steps. Samples were stained for surface or intracellular antigens, as previously described [34] . Briefly, 5 x 10 5 cells/sample were incubated with 100 µl of 20 mM ethylene diamin tetraacetic acid (EDTA) at 37 °C for 10 min. Cells were washed with 3 ml of washing buffer and centrifuged (4 ˚C, 400 X g, 8 min).
Staining of surface antigens. Samples were resuspended in 100 µl washing buffer containing the appropriate amount of surface antibodies; samples were incubated for 30 min at 4 ˚C in the dark. Cells were washed (3 ml of washing buffer), centrifuged (4 ˚C, 400 X g, 8 min), resuspended with 1ml 0.5% paraformaldehyde, incubated for 5 min at RT, washed, centrifuged (4 ˚C, 400 X g, 8min) and stored at 4 ˚C in the dark until the acquisition.
Staining of intracellular antigens for flow cytometry. Cells were resuspended in 1ml of FACS Lysing solution (BD), vortexed and incubated at room temperature (RT) in the dark for 10 min. Samples were centrifuged (4 ˚C, 400 X g, 8 min); 1 ml of Perm 2 (BD) was added to each tube and cells were incubated at RT in the dark for 10 min. Samples were washed and centrifuged (4 ˚C, 400 X g, 8 min). Cells were resuspended in 100 µl of washing buffer containing the appropriate amount of intracellular antibodies and incubated for 30 min at 4 ˚C in the dark. Cells were centrifuged (4 ˚C, 400 X g, 8 min), resuspended with 1 ml 0.5 % paraformaldehyde, incubated for 5 min at RT, washed, centrifuged (4 ˚C, 400 X g, 8 min) and stored at 4 ˚C in the dark until the acquisition. Cells were analysed on a FACSCalibur flow cytometer (BD), using CellQuest™ software (BD).
Flow Cytometry Measurement
Quality control included regular check-up with Rainbow Calibration Particles (BD Biosciences). Debris was excluded from the analysis by gating on morphological parameters; 20,000 non-debris events in the morphological gate were recorded for each sample. To assess non-specific fluorescence we used isotype controls. All antibodies were titrated under assay conditions and optimal photomultiplier voltages (PMT) were established for each channel [35] . Data were analysed using FlowJo™ software (TreeStar, Ashland, OR). Mean Fluorescence Intensity Ratio (MFI Ratio) was calculated dividing the MFI of positive events by the MFI of negative events [36] . Fig. (1A) displays the umbilical cord internal organization and the compartment from where WJ-MSCs originate. Fig. (1B) shows the first step of MSC isolation, consisting in the cord vessel removal, followed by the scalp of Wharton's Jelly and its enzymatic digestion. The collection of WJMSCs umbilical cord-derived from healthy and diabetic mothers showed a comparable success rate (not shown). Different WJ-MSCs derived from umbilical cords of healthy (n = 5) and diabetic (n = 5) mothers were studied for their proliferative ability. No statistically significant differences of the proliferative rates were seen, even if a slight increase of proliferative index was observed in WJ-MSCs from diabetic mothers (Fig. 1C) . Primary WJ-MSCs cultures, obtained from umbilical cords of healthy (Fig. 1D) and diabetic (Fig.  1E ) mothers showed comparable morphological features.
RESULTS
Purification and Proliferation Potential of WJ-MSCs
WJ-MSC Osteogenic Differentiation
When osteogenic differentiation was induced, the same morphological differentiation were observed in WJ-MSCs phase-contrast images obtained from healthy ( Fig. 2A) and diabetic mothers (Fig. 2B) after Alizarin Red S staining. Respect to the phase-contrast images, results obtained by brightfield observation (Fig. (2C) healthy; Fig. (2D) diabetic) broader shows the extracellular mineralized matrix deposition, pointed by arrows. The histogram in Fig. (2E) represents the quantitative evaluation of Alizarin Red S staining by a colorimetric method. There are no significant statistical differences between healthy (gray bars) and diabetic (black bars) WJ-MSC, both in control and osteogenic differentiation conditions. Further confirmation that osteogenic differentiation is comparable in both groups of samples is the frequency of positive cells to the alkaline phosphatase reaction, showed as brightfield images of WJ-MSCs obtained from healthy (Fig. 2F) and diabetic (Fig. 2G) mothers and also showed as percentage of alkaline phosphatase reaction positive cells obtained by counting the total and positive cells (Fig. 2H) . 
WJ-MSC Adipogenic Differentiation
Adipogenic differentiation of WJ-MSCs obtained from both sources was also induced. The lipid droplets accumulation, after three weeks of induction, was more widespread and abundant in WJ-MSCs obtained from diabetic mothers (Fig. 3B) compared to healthy mothers (Fig. 3A) . In detail, Fig. (3C) shows that WJ-MSCs obtained from diabetic mothers presented a statistically significant (p < 0.01) increase of positive cell percentage (56.3 ± 4.2) to the "oil red O" neutral lipid specific reaction, compared to WJ-MSCs obtained from healthy mothers (29.1 ± 1.1). To further confirm the different ability of the two WJ-MSC groups to differentiate into adipocytes, the amount of neutral lipid per positive cell was assessed by image analysis (MetaMorph software). WJ-MSCs obtained from diabetic mothers had a high propensity (healthy 3.7 ± 1.1 A.U. and diabetic 13.2 ± 2.8 A.U.; p < 0.001) to accumulate lipid droplets with respect to WJ-MSCs obtained from healthy mothers (Fig.  3D) .
This finding was further confirmed by Real Time RT-PCR for PPARγ (Fig. 3E) and FABP4 (Fig. 3F) respectively of WJ-MSCs from healthy (gray bars) and diabetic (black bars) mothers. Adipogenic differentiation leads to a doubling of PPARγ expression (from 14.5116 to 22.5420 2 -∆∆Ct ) and a roughly five fold increase of FABP4 expression (from 19.1387 to 97.3509 2 -∆∆Ct ) in WJ-MSC from diabetic when compared to healthy mother.
Flow Cytometric Analysis
Flow cytometric comparison of the two groups was carried out to evaluate differences between the two sources. The phenotypes of the two WJ-MSC groups were comparable, matching with the typical phenotype of MSCs (Fig.  4 and Table 1 ) [37] . The statistical analysis ( Table 1 ) of MFI ratios showed that both WJ-MSC sources were characterized by a set of antigens expressed at comparable levels (CD13, CD14, CD45, CD144, CD34, CD105, CD133, ESA, KDR, Sox2, CD271, CD146, OCT3/4, CD117). Furthermore Table  1 shows that some other antigens were differently expressed on WJ-MSCs stemming from the two sources. CD44 (healthy 54.6 ± 3.3; diabetic 97.9 ± 4.9; p < 0.001), CD29 (healthy 27.4 ± 1.5; diabetic 42.3 ± 2.1; p < 0.009), CD73 (healthy 16.1 ± 1.2; diabetic 29.5 ± 1.7; p < 0.010), CD166 (healthy 4.4 ± 0.4; diabetic 11.8 ± 0.7; p < 0.004), SSEA4 (healthy 3.3 ± 0.3; diabetic 8.5 ± 0.2; p < 0.001) and TERT (healthy 278.3 ± 21.0; diabetic 513.6 ± 28.4; p < 0.002) were higher, whereas CD90 (healthy 69.2 ± 2.9; diabetic 54.1 ± 3.3; p < 0.008) was lower in WJ-MSCs obtained from diabetic mothers compared to healthy mothers.
CONCLUSION AND DISCUSSION
Increasing evidence suggests that disturbances in the intrauterine metabolic environment produced by hyperglycemia during pregnancy (pregestational diabetes mellitus and GDM) appear to increase the risk in offspring for obesity and diabetes [11, 12, 38] . There is increasing interest in the hypothesis that cardiovascular and metabolic diseases could be influenced by early life events. Several studies have suggested that exposure to maternal hyperglycemia increases the risk of type 2 diabetes and obesity in later life [11, 12, 38] . The measures of obesity were significantly correlated with maternal levels of fasting and postprandial blood glucose [39] [40] [41] . Catalano et al. published a series of studies comparing the body composition analysis of infants of women with normal glucose tolerance (NGT) and GDM within 48 h of birth. Although there was no significant difference in birth weight or fat-free mass between the groups, there was a significant increase in fat mass and percent body fat in the infants of the GDM mothers. There was again a significant increase in fat mass, percent body fat, and skinfold measures in the infants of the GDM mothers compared with the NGT [42] . The HAPO Study has demonstrated a continuous relation between maternal blood glucose and perinatal macrosomia and adiposity [14, 15] . Linday et al., recently showed an increased risk of overweight and obesity in offspring of mothers with Type 1 Diabetes [43] . The increase of the prevalence of obesity, diabetes 2 and cardiovascular disease constitutes a "health threat to the individual and it is a major burden for health economy" [38] and several studies have pointed out the possible role of intrauterine hyperglycemia in the pathogenesis of obesity and type 2 diabetes [38, 44] . Following the above evidences we have decided to study the effect of maternal glycemia on the differentiation of mesenchymal stem cells. A recent study in rodents suggests that the determination of mesenchymal stem cells into preadipocytes might occur in very early stages of development, e.g. perinatal life [27] . Since the number of preadipocytes and mature fat cells has been shown to be different between lean and obese human adult subjects [28] , variations in the determination process in early stages of adipose tissue development might be important in the pathogenesis of obesity and type 2 diabetes. For this reason it would be useful to investigate how the perinatal environment may affect fetal mesenchymal stem cells, especially in deregulated diabetes during pregnancy, where the fetal environment is modified in terms of hormone levels and nutrition. Therefore, we have compared Wharton's jelly mesenchymal stem cells (WJ-MSC) obtained from umbilical cord in healthy and diabetic women, in order to better understand the mechanisms involved in metabolic diseases in offspring of diabetic mothers. WJ-MSC of healthy and diabetic mothers were morphologically comparable and disclosed similar phenotypes. Although the same markers were expressed in WJ-MSCs obtained from healthy or diabetic mothers, their expression levels differed possibly in relationship with different functional characteristics of the two WJ-MSC groups. We demonstrated lower levels of CD90 in WJ-MSCs from diabetic mothers, which could be associated to a plasticity decrease of these cells [45] . We also showed that WJ-MSCs from diabetic mothers presented a higher adipocyte differentiation efficiency, compared to WJMSCs obtained from healthy mothers, suggesting, therefore, a possible pre-commitment of these cells to the adipogenic lineage. In addition, the up-regulation of CD44, CD29, CD73, CD166, SSEA4 and TERT in WJ-MSCs obtained from diabetic mothers, shown in this study, might be related to the slight increase of proliferative ability of these cells. With regard to the plasticity, WJ-MSCs obtained from diabetic mothers were significantly more oriented to the adipogenic differentiation, as compared to WJ-MSCs obtained from healthy mothers, and as demonstrated by the presence of more evident a higher preadipocyte number, as well as an increased lipid droplet size other than by up regulation of PPARγ and FABP4. The increased capacity of the WJ-MSCs obtained from diabetic mothers to differentiate into adipogenic lineage suggests that the uterine environment induces a series of changes responsible for a "pre-commitment". For this reason, it is conceivable that the uterine environment influences these cells and, following an unbalanced diet in the postnatal life, could result in an abnormal accumulation of adipose tissue. Leading to the development of severe obesity associated with metabolic-related disorders. These data, provide interesting cues that could contribute to explain the pathophysiological mechanisms of obesity origin and associated metabolic disorders.
